While our work focuses on the role of NOTCH1 in inducing tumor-intrinsic STING expression and activation, NOTCH1 has been shown to inhibit STING activation in CD4+ T cells via binding to the cyclic dinucleotide binding site (62). The gene discussed is NOTCH1; the disease is neoplasm.